The (16), have provided evidence that this metabolite has potent biological activity in stimulating intestinal calcium transport. This metabolite acts more rapidly in initiating intestinal calcium transport than does 25-(OH)D3 (17-19), but it is less effective in curing rickets in rats than 25-(OH)D3 (18) and is no more active than 25-(OH)D3 in stimulating bone mineral mobilization (18). In any case, the present evidence would strongly suggest that this polar metabolite ("peak V") represents the metabolically active form of the vitamin in the intestine. This metabolite was recently isolated in pure form from intestine and identified conclusively as 1,25-(OH)2D3 (20) , in agreement with a structure deduced (21) from a preparation of 30% purity.
reported that actinomycin D blocks vitamin D-stimulated intestinal absorption of calcium in chickens. Further studies (3) provided very strong evidence that the mechanism of vitamin D action both in the intestine and in bone must involve transcription of DNA and protein synthesis. The concept was further strengthened when it was demonstrated that nuclear RNA labeling by [3H]orotic acid or [3H]uridine could be stimulated by vitamin D in both rats (4) and chicks (5) . Since form from the plasma of pigs and was identified as 25-hydroxycholecalciferol 25-(OH)D3 (8). Strong evidence has since then been provided that 25-hydroxylation represents the initial step in the functional metabolism of the vitamin (9) . Still other work has demonstrated that 25-(OH)D3 represents the major circulating active form of the vitamin and thus may be considered a hormonal form (9, 10 (17) (18) (19) , but it is less effective in curing rickets in rats than 25-(OH)D3 (18) and is no more active than 25-(OH)D3 in stimulating bone mineral mobilization (18) . In any case, the present evidence would strongly suggest that this polar metabolite ("peak V") represents the metabolically active form of the vitamin in the intestine. This metabolite was recently isolated in pure form from intestine and identified conclusively as 1,25-(OH)2D3 (20) , in agreement with a structure deduced (21) from a preparation of 30% purity.
Of significance is the recent finding (22) (23) . For all of the intestinal calcium transport work, the rats were fed the adequate calcium and phosphorus diet for 4-5 weeks, at which time they ceased to grow and exhibited a severe hypocalcemia (about 4-5 mg calcium/100 ml of plasma); these rats were used for the everted intestinal sac experiments.
Radioactive Compounds. The [1,2-3H]vitamin D3 was synthesized as previously described (24) , and had a specific activity of 0.6 Ci/mmol. The [26,27- volume of vehicle at the indicated times. The rats were killed by decapitation and the intestine or kidneys were immediately excised. The intestine was slit lengthwise and rinsed in ice-cold isotonic saline, and the mucosa were scraped from the intestine, which rested on a stainless-steel plate embedded in ice. A tissue homogenate (25%/o in distilled water) was prepared and then immediately extracted with methanol and chloroform (6) . The chloroform extracts thus obtained were chromatographed on 2 X 20 cm Sephadex LH-20 gel columns in a solvent of 65% chloroform in petroleum ether (bp 67-69°C) (27) (Fig. 1) . Because it appears that the kidney is the primary, if not the sole, site of synthesis of 1,25-(OH)2D,3 (28, 29) , it was of interest to determine whether inhibition of the accumulation of 1,25-(OH)2D3 could be observed in this tissue. Clearly, the actinomycin D also prevented the appearance of 1,25-(OH)2D3 in the kidney after injection of 25-(OH)D3 (Fig. 1) . These findings, and those suggesting that 1,25-(OH)2 D3 represents the metabolically active form of 25-(OH)D3 in the intestine, raise the question of whether the actinomycin D-sensitive step in the vitamin Dinduced increase in intestinal calcium transport might not be the formation of 1,25-(OH), D3 in the kidney.
The results shown in Table 1 provide the necessary evidence that the action of 25-(OH)D,, like that of vitamin D (1, 3) , in inducing intestinal calcium transport is blocked by the prior administration of actinomycin D, although at doses higher than 65 pmol of 25-(OH)D3 per rat the block is incomplete. This may be related to the incomplete block in the production of 1,25-(OH)2D,3 by actinomycin ( Fig. 1) port also support the previous conclusion that 25-(OH)D3 probably induces the formation of an enzyme or enzymes involved in the production of 1,25-(OH)2D3. Recently, it has been clearly demonstrated (28, 29) that the kidney is the primary, if not the sole, site of synthesis of 1,25-(OH)2D3. This finding raises the question of why tritium derived either from vitamin D3 or from 25-(OH)D3 in the intestine is located in cell nuclei (4, 13) .
